ALPRAZOLAM | A074342 | ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Highest NADAC/Unit
$0.0485
per ea
Lowest NADAC/Unit
$0.0223
per ea
Brand NDCs
0
Generic NDCs
10
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00228203910ALPRAZOLAM 2 MG TABLET | $0.0485 | EA | Generic | — | 2026-08-19 |
| 00228203196ALPRAZOLAM 1 MG TABLET | $0.0242 | EA | Generic | — | 2026-08-19 |
| 00228203110ALPRAZOLAM 1 MG TABLET | $0.0242 | EA | Generic | — | 2026-08-19 |
| 00228203150ALPRAZOLAM 1 MG TABLET | $0.0242 | EA | Generic | — | 2026-08-19 |
| 00228202710ALPRAZOLAM 0.25 MG TABLET | $0.0239 | EA | Generic | — | 2026-08-19 |
| 00228202750ALPRAZOLAM 0.25 MG TABLET | $0.0239 | EA | Generic | — | 2026-08-19 |
Showing 6 of 10 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.